Tolentino, Primo E.

HRN: 27-19-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2026
CLINDAMYCIN 300MG (CAP)
05/10/2026
05/17/2026
PO
300mg
Q6
HERPES ZOSTER
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines